Alpha 2.0
Login Register
» Authors » Richard Riley

Richard Riley

Explore the profile of Richard Riley including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 1223
Followers 0
Related Specialties
General Medicine
Public Health
Health Services
Top 10 Co-Authors
Danielle Van der Windt
Shakila Thangaratinam
Tom Hughes
Jamie C Sergeant
Michael J Callaghan
Krishnarajah Nirantharakumar
Abhishek Abhishek
Catrin Tudur Smith
Ana Pilar Betran
Tim Card
Published In
BMJ Open
Diagn Progn Res
RMD Open
PLoS Med
Aust Fam Physician
Affiliations
Soon will be listed here.
Recent Articles
1.
Development and internal validation of prognostic models for event-free survival in newly diagnosed Ewing sarcoma patients based on routinely collected clinical characteristics from the European randomised controlled trial, EE2012
Kirton L, Riley R, Gaunt P, Brennan B, Snell K
BMJ Open . 2025 Jan; 14(12):e082941. PMID: 39806614
Introduction: Ewing sarcoma is a rare paediatric cancer. Currently, there is no way of accurately predicting these patients' survival at diagnosis. Disease type (ie, localised disease, lung/pleuropulmonary metastases and other...
2.
Risk-stratified monitoring for sulfasalazine toxicity: prognostic model development and validation
Abhishek A, Grainge M, Card T, Williams H, Taal M, Aithal G, et al.
RMD Open . 2024 Mar; 10(1). PMID: 38453215
Background: Sulfasalazine-induced cytopenia, nephrotoxicity and hepatotoxicity is uncommon during long-term treatment. Some guidelines recommend 3 monthly monitoring blood tests indefinitely during long-term treatment while others recommend stopping monitoring after 1...
3.
Prognostic factors for liver, blood and kidney adverse events from glucocorticoid sparing immune-suppressing drugs in immune-mediated inflammatory diseases: a prognostic systematic review
Leaviss J, Carroll C, Essat M, Van der Windt D, Grainge M, Card T, et al.
RMD Open . 2024 Jan; 10(1). PMID: 38199851
Background: Immune-suppressing drugs can cause liver, kidney or blood toxicity. Prognostic factors for these adverse-events are poorly understood. Purpose: To ascertain prognostic factors associated with liver, blood or kidney adverse-events...
4.
Factors affecting the implementation of calcium supplementation strategies during pregnancy to prevent pre-eclampsia: a mixed-methods systematic review
Cormick G, Moraa H, Zahroh R, Allotey J, Rocha T, Pena-Rosas J, et al.
BMJ Open . 2023 Dec; 13(12):e070677. PMID: 38135336
Objectives: Daily calcium supplements are recommended for pregnant women from 20 weeks' gestation to prevent pre-eclampsia in populations with low dietary calcium intake. We aimed to improve understanding of barriers...
5.
Calcium supplementation to prevent pre-eclampsia: protocol for an individual participant data meta-analysis, network meta-analysis and health economic evaluation
Rocha T, Allotey J, Palacios A, Vogel J, Smits L, Carroli G, et al.
BMJ Open . 2023 May; 13(5):e065538. PMID: 37169508
Introduction: Low dietary calcium intake is a risk factor for pre-eclampsia, a major contributor to maternal and perinatal mortality and morbidity worldwide. Calcium supplementation can prevent pre-eclampsia in women with...
6.
Can prognostic factors for indirect muscle injuries in elite football (soccer) players be identified using data from preseason screening? An exploratory analysis using routinely collected periodic health examination records
Hughes T, Riley R, Callaghan M, Sergeant J
BMJ Open . 2023 Jan; 13(1):e052772. PMID: 36693686
Background: In elite football, periodic health examination (PHE) may be useful for injury risk prediction. Objective: To explore whether PHE-derived variables are prognostic factors for indirect muscle injuries (IMIs) in...
7.
Association of pregnancy complications/risk factors with the development of future long-term health conditions in women: overarching protocol for umbrella reviews
Singh M, Crowe F, Thangaratinam S, Abel K, Black M, Okoth K, et al.
BMJ Open . 2022 Dec; 12(12):e066476. PMID: 36581409
Introduction: With good medical care, most pregnancy complications like pre-eclampsia, gestational diabetes, etc resolve after childbirth. However, pregnancy complications are known to be associated with an increased risk of new...
8.
Protocol for development and validation of postpartum cardiovascular disease (CVD) risk prediction model incorporating reproductive and pregnancy-related candidate predictors
Wambua S, Crowe F, Thangaratinam S, OReilly D, McCowan C, Brophy S, et al.
Diagn Progn Res . 2022 Dec; 6(1):23. PMID: 36536453
Background: Cardiovascular disease (CVD) is a leading cause of death among women. CVD is associated with reduced quality of life, significant treatment and management costs, and lost productivity. Estimating the...
9.
Incidence and pattern of mycophenolate discontinuation associated with abnormal monitoring blood-test results: cohort study using data from the Clinical Practice Research Datalink Aurum
Nakafero G, Grainge M, Card T, Mallen C, Riley R, Van der Windt D, et al.
Rheumatol Adv Pract . 2022 Jun; 6(2):rkac046. PMID: 35702565
Objective: The aim was to examine the incidence and pattern of MMF discontinuation associated with abnormal monitoring blood-test results. Methods: Data from people prescribed MMF for common inflammatory conditions in...
10.
Study protocol for the development and internal validation of Schizophrenia Prediction of Resistance to Treatment (SPIRIT): a clinical tool for predicting risk of treatment resistance to antipsychotics in first-episode schizophrenia
Farooq S, Hattle M, Dazzan P, Kingstone T, Ajnakina O, Shiers D, et al.
BMJ Open . 2022 Apr; 12(4):e056420. PMID: 35396294
Introduction: Treatment-resistant schizophrenia (TRS) is associated with significant impairment of functioning and high treatment costs. Identification of patients at high risk of TRS at the time of their initial diagnosis...